03/18/2010 05:12 am ET | Updated Nov 17, 2011

Bottling The Entrepreneurial Spirit

UK Scientists studied tech entrepreneurs and found (duh) that they exhibit more "highly adaptive risk-taking behavior" than their non-startup, corporate-slaving counterparts. They suggest that this difference results in better outcomes during stressful business situations.

The research, which was published in Nature magazine, also suggests that these risk-taking tendencies are linked to the neurotransmitter dopamine. Because the ability to make quick decisions under stress "may have evolutionary value as a means of seizing opportunities in a rapidly changing environment", there's talk of developing drugs to aid the risk-adverse.

If being risk-adverse is your only "flaw", and all your other entrepreneurial stars are aligned... then why not?

Putting health reasons aside, society doesn't consider risk-aversion as a cognitive deficit. It's socially acceptable (or is it?) to take drugs for dyslexia, ADD, and the like; but a business person taking risk-aversion drugs is more like an athlete taking steroids.

Pharmacological-induced "entrepreneurship" won't create successful entrepreneurs. It will only promote risky behavior without the attached risk-calculation and thoughtfulness. A true entrepreneur will figure it out. She will know her weakness and surround herself with those who compensate. And that is nothing you can bottle.

Subscribe to the Lifestyle email.
We’re basically your best friend… with better taste.